Feed MLECW
Summary
30 / 100 · Bulios Score
Valuation 100Growth -Profitability 13Quality 21Debt 0Stability 1
What speaks for it
- It bought back its own shares for $926.9K in the last fiscal year, 803% of its market value.
- The price moves less than the market (beta 0.09).
What to watch
- The company made a loss over the last 12 months.
- It passes only 1 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Revenue (USD)
2020202120222023202420262027
Diluted EPS (USD)
2020202120222023202420262027
- Analyst estimate
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Cash and short-term investments $1.08M
Debt $66.5M
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2024By product
The company reports no revenue by product.
By region
- ARGENTINA 74%
- North America 9.7%
- Latin America 7.7%
- BRAZIL 5.7%
- Europe Middle East And Africa Member 2.5%
ARGENTINA brings in 74% of revenue.
Segments in detail